Table 3.
99mTc‐PYP Cardiac Data Changes Between the Eplontersen Group and the Control Group*
Semi quantitative analysis | Eplontersen group (n=6) | Control group (n=7) | P value |
---|---|---|---|
Baseline planar H/CL ratio | 1.561±0.105 | 1.701±0.171 | 0.234 |
Baseline volumetric H/L ratio | 3.774±0.474 | 4.079±0.534 | 0.317 |
ΔPlanar H/CL ratio | −0.086±0.138 | −0.044±0.181 | 0.721 |
ΔVolumetric H/L ratio | −0.797±0.351 | −0.164±0.349 | 0.010† |
Change in planar H/CL ratio, % | −5.299±8.879 | −1.930±10.397 | 0.475 |
Change in volumetric H/L ratio, % | −20.703±7.821 | −3.402±8.128 | 0.007‡ |
Follow‐up time, d | 607.51 [526–850] | 491.00 [195–644] | 0.445 |
99mTc‐PYP indicates technetium‐99m‐pyrophosphate; H/CL ratio, heart and contralateral lung ratio; and H/L ratio, heart and lung ratio.
Data are given as mean±SD or median [first quartile–third quartile].
P<0.05.
P<0.01.